Evaluating Modular CAR T Manufacturing Workflows: Performance, Flexibility, And Scale

As CAR T programs move toward commercial-scale manufacturing, increasing throughput without compromising cell quality becomes a critical challenge. A modular approach offers an alternative path, enabling greater control across key manufacturing steps while supporting adaptation as process requirements evolve. Comparative data demonstrate performance across critical measures, including T cell activation and expansion, transduction efficiency, CAR+ T cell yield, phenotype preservation, and cell isolation. In addition, modular workflows can support parallel processing and reduce instrument lock time, helping manufacturers improve throughput while maintaining consistency.

Discover practical considerations for designing flexible CAR T manufacturing processes that can support the transition from process development through commercial production.